AI assistant could help junior doctors plan lung cancer surgeries

NCT ID NCT07654036

First seen Jun 25, 2026 · Last updated Jul 31, 2026 · Updated 5 times

Summary

This study tests a new AI tool called GAPS-Agent that helps doctors plan surgeries for lung cancer. The tool is designed to assist less experienced doctors in making complex decisions. Researchers will compare AI-generated plans to those from a standard AI, and expert surgeons will judge which plans are better. The study is very small with only 12 participants and aims to gather initial data for larger future trials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
GAPS-Agent (an AI tool that helps doctors plan lung cancer surgeries)
What this could lead to
If successful, this could show that AI can help less experienced doctors create better surgical plans for lung cancer, potentially improving patient care.
What could go wrong
This is a very small, early study with only 12 participants. It measures expert preference, not actual patient outcomes, so the real-world benefit is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LARGE LANGUAGE MODELS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Peking University People's Hospital

    Beijing, Beijing Municipality, 100044, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.